Oliver Bannach

838 total citations
33 papers, 562 citations indexed

About

Oliver Bannach is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Oliver Bannach has authored 33 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 12 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Oliver Bannach's work include Alzheimer's disease research and treatments (23 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Oliver Bannach is often cited by papers focused on Alzheimer's disease research and treatments (23 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Oliver Bannach collaborates with scholars based in Germany, Sweden and United States. Oliver Bannach's co-authors include Dieter Willbold, Detlev Riesner, Eva Birkmann, Andreas Kulawik, Gerhard Steger, Christian Zafiu, Michael M. Wördehoff, Hamed Shaykhalishahi, Wolfgang Hoyer and Sabine Willbold and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.

In The Last Decade

Oliver Bannach

31 papers receiving 551 citations

Peers

Oliver Bannach
Patrick Downey Belgium
Kiyouhisa Ohnishi Japan
Anna Stachowiak Poland
S. A. Bobin United States
Tanaporn Wangsanut Thailand
Ravi Kant Agarwal India
Dean F. Revell United Kingdom
Catherine Viel United States
Kathleen A. Harrington United Kingdom
Patrick Downey Belgium
Oliver Bannach
Citations per year, relative to Oliver Bannach Oliver Bannach (= 1×) peers Patrick Downey

Countries citing papers authored by Oliver Bannach

Since Specialization
Citations

This map shows the geographic impact of Oliver Bannach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Bannach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Bannach more than expected).

Fields of papers citing papers by Oliver Bannach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Bannach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Bannach. The network helps show where Oliver Bannach may publish in the future.

Co-authorship network of co-authors of Oliver Bannach

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Bannach. A scholar is included among the top collaborators of Oliver Bannach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Bannach. Oliver Bannach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bannach, Oliver, et al.. (2024). IAPP - oligomerisation levels in plasma of people with type 2 diabetes. Scientific Reports. 14(1). 1 indexed citations
2.
Kutzsche, Janine, Markus Tusche, Michael T. Barbe, et al.. (2024). Elevated Aβ aggregates in feces from Alzheimer’s disease patients: a proof-of-concept study. Alzheimer s Research & Therapy. 16(1). 223–223. 1 indexed citations
3.
Seger, Aline, Hannah Jergas, Oliver Bannach, et al.. (2023). Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool. npj Parkinson s Disease. 9(1). 14–14. 25 indexed citations
4.
Eberle, Raphael J., Mônika A. Coronado, Anja Stefanski, et al.. (2023). Tau protein aggregation associated with SARS-CoV-2 main protease. PLoS ONE. 18(8). e0288138–e0288138. 8 indexed citations
5.
6.
Engberg, Göran, Fredrik Piehl, Simon Červenka, et al.. (2023). Disrupted‐in‐schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first‐episode psychosis. Psychiatry and Clinical Neurosciences. 77(12). 665–671. 7 indexed citations
7.
Zafiu, Christian, et al.. (2022). Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Reports Medicine. 3(5). 100630–100630. 23 indexed citations
8.
Zafiu, Christian, Sonja Hartwig, Stefan Lehr, et al.. (2018). Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology. Molecular Neurobiology. 56(3). 2211–2223. 31 indexed citations
9.
10.
Kulawik, Andreas, et al.. (2016). sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body fluids. Clinical Biochemistry. 50(4-5). 244–247. 12 indexed citations
11.
Kravchenko, Kateryna, et al.. (2016). Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay. Frontiers in Neuroscience. 10. 8–8. 23 indexed citations
12.
Shaykhalishahi, Hamed, Aziz Gauhar, Michael M. Wördehoff, et al.. (2015). Contact between the β1 and β2 Segments of α‐Synuclein that Inhibits Amyloid Formation. Angewandte Chemie International Edition. 54(30). 8837–8840. 25 indexed citations
13.
Wördehoff, Michael M., Oliver Bannach, Hamed Shaykhalishahi, et al.. (2015). Single Fibril Growth Kinetics of α-Synuclein. Journal of Molecular Biology. 427(6). 1428–1435. 50 indexed citations
14.
Funke, Susanne Aileen, Kun Wang, Astrid Besmehn, et al.. (2013). The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease. Journal of Alzheimer s Disease. 34(4). 985–994. 58 indexed citations
15.
Bannach, Oliver, Jan Stöhr, Michael M. Wördehoff, et al.. (2013). Seeded Fibrillation as Molecular Basis of the Species Barrier in Human Prion Diseases. PLoS ONE. 8(8). e72623–e72623. 14 indexed citations
16.
Bannach, Oliver, Elke Reinartz, Anja M. Oelschlegel, et al.. (2013). Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE cases. Veterinary Microbiology. 166(1-2). 102–108. 6 indexed citations
17.
Bannach, Oliver, Eva Birkmann, Elke Reinartz, et al.. (2012). Detection of Prion Protein Particles in Blood Plasma of Scrapie Infected Sheep. PLoS ONE. 7(5). e36620–e36620. 34 indexed citations
18.
Fu, Yan, Oliver Bannach, Hao Chen, et al.. (2009). Alternative splicing of anciently exonized 5S rRNA regulates plant transcription factor TFIIIA. Genome Research. 19(5). 913–921. 33 indexed citations
19.
Matoušek, Jaroslav, et al.. (2007). Accumulation of viroid-specific small RNAs and increase in nucleolytic activities linked to viroid-caused pathogenesis. Biological Chemistry. 388(1). 1–13. 65 indexed citations
20.
Bannach, Oliver, Kanghong Hu, Michaela Moors, et al.. (2006). Transcription of potato spindle tuber viroid by RNA polymerase II starts in the left terminal loop. Virology. 347(2). 392–404. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Downey Breakdown of academic impact, for papers by Kiyouhisa Ohnishi Breakdown of academic impact, for papers by Anna Stachowiak Breakdown of academic impact, for papers by S. A. Bobin Breakdown of academic impact, for papers by Tanaporn Wangsanut Breakdown of academic impact, for papers by Ravi Kant Agarwal Breakdown of academic impact, for papers by Dean F. Revell Breakdown of academic impact, for papers by Catherine Viel Breakdown of academic impact, for papers by Kathleen A. Harrington
Rankless by CCL
2026